$TGTX News TG Therapeutics (TGTX) Worth Watching: Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2014 at 12:29 PM

$TGTX News

TG Therapeutics (TGTX) Worth Watching: Stock Up 9.1% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog 5:10 p.m. Aug. 18, 2014 - Zacks.com
Falling Earnings Estimates Signal Weakness Ahead for TG Therapeutics (TGTX) - Tale of the Tape 8:27 a.m. Aug. 8, 2014 - Zacks.com
Ligand: Pipeline Breakdown Reveals Bullish Outlook 9:12 a.m. July 30, 2014 - Seeking Alpha
10-Q: TG THERAPEUTICS, INC. 4:38 p.m. July 24, 2014 - Edgar Online - (EDG = 10Q, 10K)
TG Therapeutics' (TGTX) CEO Mike Weiss on Q2 2014 Results - Earnings Call Transcript 2:56 p.m. July 22, 2014 - Seeking Alpha
TG Therapeutics (TGTX) in Focus: Stock Moves 10.4% Higher - Tale of the Tape 9:25 a.m. July 3, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
TG Therapeutics (TGTX) is Overbought: Is A Drop Coming? - Tale of the Tape 9:19 a.m. June 25, 2014 - Zacks.com
Strength Seen in TG Therapeutics, Inc. (TGTX) as Stock Rallies 12.94% - Tale of the Tape 8:44 a.m. June 24, 2014 - Zacks.com
A new partnership to develop IRAK-4 inhibitors 7:41 a.m. June 24, 2014 - Seeking Alpha
TG Therapeutics (TGTX) Crumbles: Stock Falls by 6.6% - Tale of the Tape 8:41 a.m. June 19, 2014 - Zacks.com
TG Therapeutics (TGTX) Catches Eye: Stock Surges 20.8% in Session - Tale of the Tape 8:37 a.m. June 13, 2014 - Zacks.com
Interim Phase 2 results for TG Therapeutics' cancer mAb 7:48 a.m. June 13, 2014 - Seeking Alpha
Bullish chart action for TG Therapeutics 5:23 p.m. June 12, 2014 - Seeking Alpha
Market Crash in the Cards? 3 Stocks to Book Profits - Investment Ideas 4:06 a.m. June 4, 2014 - Zacks.com
TG Therapeutics' (TGTX) CEO Michael Weiss on Q1 2014 Results - Earnings Call Transcript 1:31 p.m. May 13, 2014 - Seeking Alpha
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
TG Therapeutics Gets A Triple Thumbs Up From The Baker Brothers 11:23 a.m. March 13, 2014 - Seeking Alpha
TG Therapeutics (TGTX) is Overbought, What's Next? - Tale of the Tape 9:35 a.m. March 13, 2014 - Zacks.com

TG Therapeutics Announces Novel "Chemo-free" Triple Therapy Combination Clinical Study for Patients With Chronic Lymphocytic Leukemia and Other B-cell Malignancies 7:30 a.m. Aug. 15, 2014 - GlobeNewswire
TG Therapeutics' Novel Combination of TG-1101 (Ublituximab) and TGR-1202 Demonstrates Compelling Early Activity and Safety Profile in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) and Aggressive Lymphomas 4:06 p.m. July 21, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update 4:06 p.m. July 21, 2014 - GlobeNewswire
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 4:27 p.m. July 15, 2014 - PR Newswire - PRF
Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne 5:50 a.m. July 8, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4 8:09 a.m. June 24, 2014 - GlobeNewswire
Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program 3:01 a.m. June 24, 2014 - BusinessWire - BZX
TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference 8:31 a.m. June 23, 2014 - GlobeNewswire
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference 4:30 p.m. June 16, 2014 - GlobeNewswire
TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) 5:31 a.m. June 13, 2014 - GlobeNewswire
Coronado Biosciences Announces February Inducement Award 4:06 p.m. May 9, 2014 - GlobeNewswire
TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure 8:32 a.m. May 8, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference 8:32 a.m. May 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014 8:32 a.m. April 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor 5:13 p.m. March 11, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference 10:01 a.m. March 10, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update 5:07 p.m. March 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update 9:31 a.m. March 4, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...